SCHEMBL30987478

SCHEMBL30987478

OC(CON1CCC(c2ccncc2Cl)CC1)CN1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
ATM Q13315 1/20 0.41
HTR1A P08908 1/20 0.41
HTR7 P34969 1/20 0.41
CYP2D6 P10635 3/20 0.41
CYP2C19 P33261 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 3/20 0.40
HIF1A Q16665 1/20 0.39
ACE2 Q9BYF1 1/20 0.39
KDM4E B2RXH2 2/20 0.38
KMT2A Q03164 3/20 0.37
ALOX15 P16050 1/20 0.37
RECQL P46063 1/20 0.37
ESR2 Q92731 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RAD52 P43351 1/20 0.37
NLRP1 Q9C000 1/20 0.37
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30987490 0.81 CYP11B2 (0.47) TSHRATMHTR1AHTR7CYP2D6
SCHEMBL30987481 0.75 CYP2D6 (0.50) TSHRATMCYP2D6CYP2C19POLB
SCHEMBL30987501 0.74 ADRB2 (0.54) TSHRATMCYP2D6HIF1AKMT2A
SCHEMBL30987497 0.70 KMT2A (0.52) TSHRATMCYP2D6CYP2C19POLB
SCHEMBL30987486 0.70 KMT2A (0.52) TSHRATMCYP2D6CYP2C19POLB
SCHEMBL30987489 0.70 KMT2A (0.52) TSHRATMCYP2D6CYP2C19POLB
SCHEMBL30987499 0.68 KMT2A (0.46) TSHRATMCYP2D6CYP2C19POLB
SCHEMBL30987480 0.67 DRD4 (0.46) TSHRATMCYP2D6CYP2C19POLB
SCHEMBL30987500 0.64 HTT (0.43) TSHRATMCYP2D6CYP2C19POLB
SCHEMBL3060495 0.62 HSF1 (0.60) TSHRATMCYP2D6CYP2C19POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118139842-A Oximes and their use in the treatment of GBA related diseases 泽拉丹麦有限公司 2024-06-04 CN disclosed